Kiniksa Pharmaceuticals, Ltd. License Agreements
4 Contracts & Agreements
- License Agreement, dated August 2, 2022, by and among Kiniksa Pharmaceuticals (UK), Ltd., Genentech, Inc. and F. Hoffmann-La Roche Ltd (Filed With SEC on November 3, 2022)
- Exclusive License Agreement, dated as of November 1, 2013, by and between The Beth Israel Deaconess Medical Center and Primatope Therapeutics Inc (Filed With SEC on February 24, 2022)
- Amendments Nos. 1 and 2 to the License Agreement, dated September 25, 2017, by and between Kiniksa Pharmaceuticals and Regeneron Pharmaceuticals, Inc (Filed With SEC on May 6, 2021)
- Amendment No. 1 to the License Agreement, effective as of July 9, 2020, by and between Kiniksa Pharmaceuticals, Ltd. and MedImmune Limited (Filed With SEC on July 15, 2020)
